HOME >> MEDICINE >> NEWS
Size of myocardial infarct measured using MRI

In animal studies, researchers at Johns Hopkins have effectively used magnetic resonance imaging (MRI) to measure with 94 percent accuracy the size and amount of heart muscle damaged by a heart attack, known in medical terms as a myocardial infarct, or m.i., for short.

The Hopkins development, if confirmed in further pathology studies in humans, could standardize how physicians currently gauge the severity of a heart attack and a patient's chances for recovery. A variety of methods are currently used to determine the size of an infarct by MRI, such as visual cues, but these estimates have been shown in previous studies to overestimate damage by an average of 11 percent.

The researchers, whose findings will be published in the Journal of the American College of Cardiology online Dec. 21, hope to apply this information for determining more accurate dosing regimens for stem cell therapies currently under development, in which upwards of 200 million stem cells are injected directly into the damaged heart muscle.

"The size of a heart attack matters for determining how well a patient will recover from the trauma. Current methods for measuring the size of an infarct and assessing how much damage was done are highly subjective and arbitrary," said senior study author and cardiologist Joo Lima, M.D., associate professor of medicine and radiology at The Johns Hopkins University School of Medicine and its Heart Institute. "Indeed, a person who has suffered damage to more than 30 percent of the left ventricle of the heart is twice as likely to die within a year from the injury than someone who has suffered less damage, and bigger infarcts often require more aggressive drug therapy or, in the most severe cases, surgery to repair heart tissue or prevent further damage."

The Hopkins team measured the size of an m.i. in 13 dogs using eight different methods for analyzing pictures taken by a standard MRI, ranging from visual cues to v
'"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
20-Dec-2004


Page: 1 2 3

Related medicine news :

1. Profiles of myocardial infarction among South Asian Canadians
2. No link between oral contraceptives and myocardial infarction
3. Mouse gene shows new mechanism behind cardiac infarction in man
4. Novel use of radiotracer reveals extent of mycoardial infarction damage
5. Effectiveness of drugs used to treat Parkinsons disease in early, later stages measured
6. Many children improperly measured in doctors offices
7. Indiana University researchers closer to helping hearing-impaired using stem cells
8. Tracking trends in cochlear implant complications using a federal database
9. Tumor-targeted immune cells cure prostate cancer in mice without causing systemic immune suppression
10. Over prescribing causing high rates of antibiotic resistance in south and east Europe
11. Bone density returns when teens stop using Depo Provera, Group Health study finds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Size myocardial infarct measured using MRI

(Date:6/19/2013)... The Cancer Support Community (CSC), an international ... for the whole patient with the launch today of ... This inaugural event, held at the Newseum, will feature ... of Congress members who have made a significant impact ... families currently engaged in the cancer journey. ...
(Date:6/19/2013)... Arem Wellness was developed and is managed ... Ridha Arem, who is determined to help educate the ... Arem Wellness provides a monthly newsletter, a blog, many ... well as an exceptional supplement line uniquely designed by ... role diet and nutrition have not only on ...
(Date:6/19/2013)... to the head; a swift jarring to the body and ... It’s understandable, but what else may follow a concussion injury? ... According to mayoclinic.com , usual symptoms that accompany ... other symptoms may follow, sometimes not for days or weeks ... dizziness, feeling like you’re in a fog, light or noise ...
(Date:6/19/2013)... OR (PRWEB) June 19, 2013 To survive when ... Pilot and Vietnam veteran Captain W.S. “Bud” Orr, the most important ... Speaking to host Sharon Kleyne on the Sharon Kleyne Hour Power ... kit in Vietnam, he always placed extra water ahead of guns ... weight limit on survival kits that pilots could carry on planes ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 ... of an Abbreviated New Drug Application (ANDA) for Hydroxyprogesterone ... generic version of Bristol-Myers Squibb’s drug fomerly known as ... to varied inquiries regarding the anticipated approval and market ... product. , Regarding the status of our pending ANDA, ...
Breaking Medicine News(10 mins):Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:Arem Wellness Announces a Recipe Contest 2Health News:Arem Wellness Announces a Recipe Contest 3Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- In its first major ... company dedicated to advancing development of the ... release drug therapies in patient disease populations ... the acquisition of Enzon Pharmaceutical,s PEGylation Linker ... product pipeline. Acquisition of this technology will ...
(Date:6/19/2013)... , June 19, 2013 Pharma ... new infographic summary of the results from an ... third of all respondents stated that CROs would be an ... of respondents will be running 6 or more clinical trials ... the Clinical Trial Supply USA Summit ...
(Date:6/18/2013)... 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... today that VPII Escrow Corp., a newly formed wholly ... offer of approximately $3.2 billion aggregate principal amount of ... due in 2021 and in 2023, with final tranching ... use the net proceeds from the offering, together with ...
Breaking Medicine Technology:Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
Cached News: